Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Cash Flows from Operating Activities:
Net Income (loss)	$ 9,036	$ (165,534)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	174	242
Retirement of equipment, net	8	0
(Gain)/Loss from change in fair value of hybrid financial instruments	299	31,170
(Gain)/Loss from change in fair value of derivative liability - warrants	(3,122)	41,488
(Gain)/Loss from change in fair value of derivative liability - Series C and D preferred stock and debentures	(6,774)	89,649
Interest expense related to convertible debt	0	2,392
Stock-based compensation expense	0	7
Increase/(decrease) in value of life insurance policies	0	34
Changes in operating assets and liabilities
Trade and other accounts receivable	(65)	(300)
Prepaid expenses and other assets	137	(72)
Accounts payable and accrued expenses	34	17
Deferred revenue and customer prepayments	(387)	(59)
Net cash used in operating activities	(660)	(966)
Cash Flows used Investing Activities:
Acquisition of property and equipment	0	(3)
Net cash used in investing activities	0	(3)
Cash Flows from Financing Activities:
Borrowings under convertible debt instruments, net	0	1,225
Net cash provided by financing activities	0	1,225
Effect of exchange rate changes on cash	111	8
Net change in cash and cash equivalents	(549)	264
Cash and cash equivalents, beginning of period	611	30
Cash and cash equivalents, end of period	62	294
Supplemental cash flow information:
Series C preferred stock converted to common stock	0	878
Series D preferred stock converted to common stock	0	776
Deemed dividend on Series D preferred stock issued	0	5,530
Convertible debentures converted to common stock	$ 320	$ 0